Cargando…
Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a major DNA sensor responsible for cytosolic DNA-mediated innate immune response. Inhibition of cGAS may be an effective strategy for treating autoimmune diseases such as Aicardi-Goutieres syndrome and systemic lupus erythematosus. Compound C (also known as...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059800/ https://www.ncbi.nlm.nih.gov/pubmed/32180716 http://dx.doi.org/10.3389/fphar.2020.00088 |
_version_ | 1783504122191806464 |
---|---|
author | Lai, Junzhong Luo, Xuan Tian, Shuoran Zhang, Xing Huang, Shanlu Wang, Hanze Li, Qiumei Cai, Shaoli Chen, Qi |
author_facet | Lai, Junzhong Luo, Xuan Tian, Shuoran Zhang, Xing Huang, Shanlu Wang, Hanze Li, Qiumei Cai, Shaoli Chen, Qi |
author_sort | Lai, Junzhong |
collection | PubMed |
description | Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a major DNA sensor responsible for cytosolic DNA-mediated innate immune response. Inhibition of cGAS may be an effective strategy for treating autoimmune diseases such as Aicardi-Goutieres syndrome and systemic lupus erythematosus. Compound C (also known as Dorsomorphin) has been annotated as a potent and reversible inhibitor for AMPKs as well as ALK protein kinases. Here, we report a new function of Compound C which can suppress dsDNA-dependent type I interferon induction. These effects were not dependent on the activities of AMPK proteins. In vitro assays and liquid chromatograph-mass spectrometry data show that Compound C has the capability of reducing cGAMP accumulation, suggesting that Compound C may function as a modulator involved in the cGAS-STING-mediated DNA sensing pathway. Furthermore, Compound C is able to rescue the autoimmune phenotypes in a mouse model carrying the Trex1 gene deficiency. These data demonstrate a new and inverse correlation between Compound C and type I interferon production in response to dsDNA signaling. |
format | Online Article Text |
id | pubmed-7059800 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70598002020-03-16 Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation Lai, Junzhong Luo, Xuan Tian, Shuoran Zhang, Xing Huang, Shanlu Wang, Hanze Li, Qiumei Cai, Shaoli Chen, Qi Front Pharmacol Pharmacology Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a major DNA sensor responsible for cytosolic DNA-mediated innate immune response. Inhibition of cGAS may be an effective strategy for treating autoimmune diseases such as Aicardi-Goutieres syndrome and systemic lupus erythematosus. Compound C (also known as Dorsomorphin) has been annotated as a potent and reversible inhibitor for AMPKs as well as ALK protein kinases. Here, we report a new function of Compound C which can suppress dsDNA-dependent type I interferon induction. These effects were not dependent on the activities of AMPK proteins. In vitro assays and liquid chromatograph-mass spectrometry data show that Compound C has the capability of reducing cGAMP accumulation, suggesting that Compound C may function as a modulator involved in the cGAS-STING-mediated DNA sensing pathway. Furthermore, Compound C is able to rescue the autoimmune phenotypes in a mouse model carrying the Trex1 gene deficiency. These data demonstrate a new and inverse correlation between Compound C and type I interferon production in response to dsDNA signaling. Frontiers Media S.A. 2020-02-28 /pmc/articles/PMC7059800/ /pubmed/32180716 http://dx.doi.org/10.3389/fphar.2020.00088 Text en Copyright © 2020 Lai, Luo, Tian, Zhang, Huang, Wang, Li, Cai and Chen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Lai, Junzhong Luo, Xuan Tian, Shuoran Zhang, Xing Huang, Shanlu Wang, Hanze Li, Qiumei Cai, Shaoli Chen, Qi Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation |
title | Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation |
title_full | Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation |
title_fullStr | Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation |
title_full_unstemmed | Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation |
title_short | Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation |
title_sort | compound c reducing interferon expression by inhibiting cgamp accumulation |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059800/ https://www.ncbi.nlm.nih.gov/pubmed/32180716 http://dx.doi.org/10.3389/fphar.2020.00088 |
work_keys_str_mv | AT laijunzhong compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation AT luoxuan compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation AT tianshuoran compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation AT zhangxing compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation AT huangshanlu compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation AT wanghanze compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation AT liqiumei compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation AT caishaoli compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation AT chenqi compoundcreducinginterferonexpressionbyinhibitingcgampaccumulation |